1. Home
  2. LXRX vs DDL Comparison

LXRX vs DDL Comparison

Compare LXRX & DDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • DDL
  • Stock Information
  • Founded
  • LXRX 1995
  • DDL 2014
  • Country
  • LXRX United States
  • DDL China
  • Employees
  • LXRX N/A
  • DDL N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • DDL Catalog/Specialty Distribution
  • Sector
  • LXRX Health Care
  • DDL Consumer Discretionary
  • Exchange
  • LXRX Nasdaq
  • DDL Nasdaq
  • Market Cap
  • LXRX 552.4M
  • DDL 450.9M
  • IPO Year
  • LXRX 2000
  • DDL 2021
  • Fundamental
  • Price
  • LXRX $1.38
  • DDL $1.84
  • Analyst Decision
  • LXRX Buy
  • DDL
  • Analyst Count
  • LXRX 5
  • DDL 0
  • Target Price
  • LXRX $3.23
  • DDL N/A
  • AVG Volume (30 Days)
  • LXRX 2.4M
  • DDL 814.2K
  • Earning Date
  • LXRX 11-06-2025
  • DDL 11-14-2025
  • Dividend Yield
  • LXRX N/A
  • DDL N/A
  • EPS Growth
  • LXRX N/A
  • DDL 372.99
  • EPS
  • LXRX N/A
  • DDL 0.21
  • Revenue
  • LXRX $58,432,000.00
  • DDL $3,335,962,059.00
  • Revenue This Year
  • LXRX $66.55
  • DDL $7.94
  • Revenue Next Year
  • LXRX N/A
  • DDL $10.37
  • P/E Ratio
  • LXRX N/A
  • DDL $8.89
  • Revenue Growth
  • LXRX 1504.83
  • DDL 15.14
  • 52 Week Low
  • LXRX $0.28
  • DDL $1.80
  • 52 Week High
  • LXRX $1.95
  • DDL $4.79
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 49.80
  • DDL 40.88
  • Support Level
  • LXRX $1.30
  • DDL $1.85
  • Resistance Level
  • LXRX $1.48
  • DDL $1.98
  • Average True Range (ATR)
  • LXRX 0.07
  • DDL 0.07
  • MACD
  • LXRX -0.02
  • DDL 0.00
  • Stochastic Oscillator
  • LXRX 27.77
  • DDL 24.32

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About DDL Dingdong (Cayman) Limited (each two representing three)

Dingdong (Cayman) Ltd is the fastest growing on-demand e-commerce company in China. The company directly provides users and households with fresh produce, meat and seafood, and other daily necessities through a convenient shopping experience supported by an extensive self-operated frontline fulfillment grid. It recognizes revenues from product sales of fresh groceries and other daily necessities through Dingdong Fresh APP and mini-programs and membership services.

Share on Social Networks: